Cargando…
High BTBD7 expression positive is correlated with SLUG-predicted poor prognosis in hormone receptor-negative breast cancer
BACKGROUND: Hormone receptor-negative breast cancer (HRNBC), which includes triple-negative breast cancer (TNBC) and human epidermal growth factor receptor 2 (HER-2) overexpressing breast cancer, is prone to metastasis and has a poor prognosis. BTB/POZ domain-containing protein 7 (Btbd7) is thought...
Autores principales: | Li, Zi-Xiong, Huang, Ze-Nan, Luo, Hui, Yang, Xiong-Bin, Wang, Yu-Lin, Chen, Jie-Xin, Ma, Xiao-Kai, Xu, Feng, Wang, Tian-Tian, Lin, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421947/ https://www.ncbi.nlm.nih.gov/pubmed/34532389 http://dx.doi.org/10.21037/atm-21-3409 |
Ejemplares similares
-
Association of BTBD7 with Metastasis and Poor Prognosis in Non-Small-Cell Lung Cancer Patients
por: Luo, Fan-Yan, et al.
Publicado: (2015) -
Btbd7 contributes to reduced E-cadherin expression and predicts poor prognosis in non-small cell lung cancer
por: Fan, Chuifeng, et al.
Publicado: (2014) -
The Role of BTBD7 in Normal Development and Tumor
Progression
por: Liu, Yun, et al.
Publicado: (2023) -
BTBD7 Downregulates E-Cadherin and Promotes Epithelial-Mesenchymal Transition in Lung Cancer
por: Shu, Jie, et al.
Publicado: (2019) -
BTBD10 is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma
por: Li, Jianhui, et al.
Publicado: (2022)